The presence of CIP2A and MYC at the NPC signifies that the tumor suppressive activity of PP2A-B56α is likely inhibited, potentially promoting oncogenic signaling though a PP2A-B55α-MYC axis. The gene discussed is MYC; the disease is neoplasm.